Targeted blood proteome profiling using NULISAseq identifies a high-performance biomarker panel for Aβ pathology quantification and staging.

Zheng W, Jiang Y, Wong HY, Wong WW, Cheng LKW, Cheng EYL, Wong BWY, Lo RMN, Leung SK, Ip FC, Yuen JKY, Shea YF, Wong WM, Shum CK, Wai HM, Mok VCT, Kwok TCY, Mok KY, Heslegrave A, Hardy J, Zetterberg H, Fu AKY, Ip NY

Open source

DOI: 10.1002/alz.71179
Published: 2026 Feb
Container: Alzheimer's & dementia : the journal of the Alzheimer's Association
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/alz.71179,
  title = {Targeted blood proteome profiling using NULISAseq identifies a high-performance biomarker panel for Aβ pathology quantification and staging.},
  author = {Zheng W and Jiang Y and Wong HY and Wong WW and Cheng LKW and Cheng EYL and Wong BWY and Lo RMN and Leung SK and Ip FC and Yuen JKY and Shea YF and Wong WM and Shum CK and Wai HM and Mok VCT and Kwok TCY and Mok KY and Heslegrave A and Hardy J and Zetterberg H and Fu AKY and Ip NY},
  year = {2026},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  doi = {10.1002/alz.71179},
  url = {https://doi.org/10.1002/alz.71179}
}

RIS

TY  - JOUR
TI  - Targeted blood proteome profiling using NULISAseq identifies a high-performance biomarker panel for Aβ pathology quantification and staging.
AU  - Zheng W
AU  - Jiang Y
AU  - Wong HY
AU  - Wong WW
AU  - Cheng LKW
AU  - Cheng EYL
AU  - Wong BWY
AU  - Lo RMN
AU  - Leung SK
AU  - Ip FC
AU  - Yuen JKY
AU  - Shea YF
AU  - Wong WM
AU  - Shum CK
AU  - Wai HM
AU  - Mok VCT
AU  - Kwok TCY
AU  - Mok KY
AU  - Heslegrave A
AU  - Hardy J
AU  - Zetterberg H
AU  - Fu AKY
AU  - Ip NY
PY  - 2026
JO  - Alzheimer's & dementia : the journal of the Alzheimer's Association
DO  - 10.1002/alz.71179
UR  - https://doi.org/10.1002/alz.71179
ER  -

APA

W, Z., Y, J., HY, W., WW, W., LKW, C., EYL, C., BWY, W., RMN, L., SK, L., FC, I., JKY, Y., YF, S., WM, W., CK, S., HM, W., VCT, M., TCY, K., KY, M., A, H., J, H., H, Z., AKY, F., & NY, I. (2026). Targeted blood proteome profiling using NULISAseq identifies a high-performance biomarker panel for Aβ pathology quantification and staging.. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.71179

Source records

pubmed · retrieved 2026-09-25T21:11:19.004Z
europe-pmc · retrieved 2026-09-25T21:11:19.013Z